Drug Addiction Treatment Market Report 2025

The drug addiction treatment market size has grown rapidly in recent years. It will grow from $20.81 billion in 2024 to $22.9 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth during the historic period is linked to the rising prevalence of substance use disorders, increasing demand for effective and accessible treatment options, higher incidence of drug dependency, growing awareness about addiction recovery, and expanding integration of digital and personalized treatment solutions.

The drug addiction treatment market size is expected to see strong growth in the next few years. It will grow to $33.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth projected for the forecast period is driven by growing adoption of medication-assisted treatments and behavioral therapies, expanding access to detoxification and counseling services, increasing awareness of comprehensive addiction recovery approaches, rising public awareness about addiction recovery, and strengthening government initiatives supporting treatment programs. Primary trends during the forecast period include advancements in substance use disorder treatments, introduction of low-dose medication regimens, development of combination therapies integrating behavioral and pharmacological approaches, innovations in treatment delivery methods, and creation of non-addictive alternatives.

The growing prevalence of substance use disorders is expected to fuel the expansion of the drug addiction treatment market in the coming years. Substance use disorders are chronic conditions marked by compulsive use of drugs or alcohol despite negative consequences, significantly impacting an individual’s mental, physical, and social well-being. The rise in these disorders is driven by increasing stress levels, mental health challenges, and modern lifestyle factors such as social pressures, economic instability, and easier access to addictive substances. Drug addiction treatment supports individuals by offering medical and psychological interventions aimed at reducing dependency, enhancing overall well-being, and facilitating long-term recovery through structured rehabilitation programs. For example, according to the Office for Health Improvement & Disparities (OHID), a UK-based public health agency, between April 2022 and March 2023, 290,635 adults engaged with drug and alcohol services - a slight increase from 289,215 the previous year. Thus, the escalating incidence of substance use disorders is driving growth in the drug addiction treatment market.

Key market players are leveraging technological innovations such as telehealth to improve accessibility, patient engagement, and convenience in treating substance use disorders. Telehealth services enable remote medical consultations using digital communication tools, making treatment more accessible, especially for underserved populations. For instance, in February 2023, Jovive Health, a US-based multispecialty healthcare provider, launched Medication-Assisted Treatment (MAT) services for Opioid Use Disorder (OUD) patients across clinics in California, Nevada, and Illinois. The program employs FDA-approved medications such as buprenorphine to alleviate withdrawal symptoms and cravings, supporting safe opioid cessation. Jovive’s MAT offerings include personalized multi-appointment treatment plans, online appointment booking, walk-in consultations, extended clinic hours, and telehealth options, all designed to enhance patient-centered care and accessibility.

In March 2023, Indivior PLC, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals Inc. for an undisclosed sum. This acquisition broadens Indivior’s addiction treatment portfolio by incorporating Opiant’s late-stage assets, including OPNT003, an investigational opioid overdose therapy. It also brings in a skilled team to further Indivior’s mission of developing transformative treatments for substance use disorders. The deal positions Indivior for potential revenue growth from OPNT003 and diversifies its pipeline with investigational therapies targeting alcohol and cannabinoid use disorders. Opiant Pharmaceuticals Inc. specializes in pharmacological treatments for substance use, addictive, and eating disorders.

Major players in the drug addiction treatment market are Novartis AG, Dr. Reddy’s Laboratories Ltd., Acadia Healthcare, Hikma Pharmaceuticals plc, Alkermes plc, Indivior PLC, Emergent BioSolutions Inc., Workit Health, Rusan Pharma Pvt. Ltd., Boulder Care, Bicycle Health, Eleanor Health, Affect Therapeutics, Forge Health, Orexo AB, BioCorRx Inc., Kinoxis Therapeutics Pty. Ltd., Addinex Technologies Inc., PursueCare, Aliya Health Group.

North America was the largest region in the drug addiction treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drug addiction treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the drug addiction treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Drug addiction treatment refers to professional medical and therapeutic interventions designed to help individuals stop or reduce substance use, manage withdrawal symptoms, and achieve long-term recovery and rehabilitation. It supports individuals in overcoming substance dependence, restoring physical and mental health, and reintegrating into society through structured medical and therapeutic programs.

The primary types of drug addiction treatment include opioid addiction, benzodiazepine addiction, barbiturate addiction, and others. Opioid addiction is a chronic disorder characterized by compulsive opioid use despite harmful consequences, leading to physical dependence and psychological cravings. Treatment options include inpatient rehabilitation, outpatient rehabilitation, detoxification services, aftercare and continuity programs, and medication-assisted treatment (MAT). Routes of administration include oral, parenteral, and others. Distribution occurs through hospital pharmacies, retail pharmacies, online pharmacies, and other channels. Key end users include rehabilitation centers, hospitals, clinics, and other healthcare providers.

The drug addiction treatment market research report is one of a series of new reports that provides drug addiction treatment market statistics, including the drug addiction treatment industry global market size, regional shares, competitors with the drug addiction treatment market share, detailed drug addiction treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the drug addiction treatment industry. This drug addiction treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug addiction treatment market includes revenues earned by entities by providing services such as counseling and psychotherapy services, behavioral therapy programs, family support and intervention services, telehealth and virtual recovery services, and relapse prevention and monitoring programs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

This product will be delivered within 3-5 business days.